| Santen SA - Taptiqom 15mcg/ml + 5mg/ml, unidose de collyre | | 66073 | | 01 | | Taptiqom 15mcg/ml + 5mg/ml | | unidose de collyre | | S01ED51 | | Timolol, Kombinationen | | 06.12.2016 | | |
| | Composition | | tafluprostum 0.015 mg, timololum 5.00 mg ut timololi maleas 6.84 mg, glycerolum, dinatrii phosphas dodecahydricus corresp. phosphas 1.34 mg, dinatrii edetas, polysorbatum 80, natrii hydroxidum aut acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 1 ml. | | Packungsbestandteile | | unidose de collyre | | | | | | | | Principe actif | Concentr. |
|---|
| Tafluprostum | 0.015 mg/ml | | Timolol | 5 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Tafluprostum | 0.015 mg | | Timolol | 5 mg |
| | | | Agents auxilliaires |
|---|
| Dinatrii Edetas | | Disodium Phosphate Dodecahydrate | | Glycerol | | Natrii Hydroxidum aut Acidum Hydrochloridum | | Polysorbatum 80 |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 x 0.3 ml | 22.47 | 40.85 | B | LS | Oui | | 002 | 90 x 0.3 ml | DDP | DDP | B | | Oui |
|
|
